DOW Chemical said yesterday its first-quarter earnings would be lower than expected due to reduced earnings at Marion Merrell Dow , its prescription drugs subsidiary , agencies report . Dow has a 71 per cent stake in Marion Merrell . The US chemical company said its first-quarter per-share net income could be about 25 cents below the 62 cents of a year ago . That figure was reached before one-time retiree healthcare charges . Including the charges , Dow lost Dollars 2.17 a share in the period . Marion Merrell said its first-quarter earnings could be as much as 60 to 70 per cent below average analysts ' expectations of 62 cents a share . For the first quarter ended March 31 1992 , Marion Merrell reported net income of 60 cents a share . Marion Merrell said the expected first-quarter decline was mainly due to sharply lower US sales of its major prescription products , compared with a the same period in the previous year .